PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (NASDAQ: PDGI), (the “Company”), a leading provider of global drug development services, today announced that it has opened a new Phase I clinic in Toronto, Canada and new offices in Brussels, Belgium and Milan, Italy. In addition, the Company has relocated its Zurich, Switzerland office to allow for future growth of its staff.
